A carregar...
Projeto de investigação
Development of polymeric dressings for advanced wound care based on natural polysaccharides: bacterial cellulose, FucoPol and chitin-glucan complex
Financiador
Autores
Publicações
Preparation of Porous Scaffold Based on Poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-3-hydroxyhexanoate) and FucoPol
Publication . Pereira, João Ricardo; Rafael, Ana Margarida; Esmail, Asiyah; Morais, Maria; Matos, Mariana; Marques, Ana Carolina; Reis, Maria A. M.; Freitas, Filomena; UCIBIO - Applied Molecular Biosciences Unit; DQ - Departamento de Química; DCM - Departamento de Ciência dos Materiais; CENIMAT-i3N - Centro de Investigação de Materiais (Lab. Associado I3N); MDPI - Multidisciplinary Digital Publishing Institute
This work focused on the development of porous scaffolds based on biocomposites comprising two biodegradable and biocompatible biopolymers: a terpolyester, poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-3-hydroxyhexanoate) (PHBHVHHx), and the bacterial polysaccharide FucoPol. The PHBHVHHx terpolymer was composed of 3-hydroxybutyrate (55 wt%), 3-hydroxyvalerate (21 wt%), and 3-hydroxyhexanoate (24 wt%). This hydrophobic polyester has low crystallinity and can form elastic and flexible films. Fucopol is a fucose-containing water-soluble polysaccharide that forms viscous solutions with shear thinning behavior and has demonstrated emulsion-forming and stabilizing capacity and wound healing ability. Emulsion-templating was used to fabricate PHA-based porous structures in which FucoPol acted as a bioemulsifier. Compared with the scaffolds obtained from emulsions with only water, the use of FucoPol aqueous solutions resulted in structures with improved mechanical properties, namely higher tensile strength (4.4 MPa) and a higher Young’s Modulus (85 MPa), together with an elongation at break of 52%. These features, together with the scaffolds’ high porosity and pore interconnectivity, suggest their potential to sustain cell adhesion and proliferation, which is further supported by FucoPol’s demonstrated wound healing ability. Therefore, the developed PHBHVHHx:FucoPol scaffolds arise as innovative porous bioactive structures with great potential for use in tissue engineering applications.
Bacterial cellulose production through the valorization of waste apple pulp and stale bread
Publication . Esmail, Asiyah; Morais, Maria; Yilmazer, Ugur D.; Neves, Luísa A.; Freitas, Filomena; DQ - Departamento de Química; UCIBIO - Applied Molecular Biosciences Unit; CENIMAT-i3N - Centro de Investigação de Materiais (Lab. Associado I3N); DCM - Departamento de Ciência dos Materiais; LAQV@REQUIMTE; Springer Verlag
In this work, stale bread and waste apple pulp were used as feedstocks for the production of bacterial cellulose (BC). A glucose-rich solution was prepared from stale bread by dilute acid hydrolysis, while an extract comprising fructose and glucose was obtained from the waste apple pulp, which was used for cultivating Komagataeibacter xylinus DSM 2004, either as sole feedstocks or supplemented with Hestrin-Schramm medium. Supplementation significantly improved BC production: 3.38 ± 0.09 g/L for waste apple pulp extract and 2.07 ± 0.22 g/L for stale bread hydrolysate. There was no significant impact on BC chemical structure or fiber diameter, but the biopolymer produced from waste apple pulp extract had slightly higher crystallinity (CI = 59–69%) and lower thermal degradation temperature (Tdeg = 341–350 ℃) than that of the stale bread hydrolysate (CI = 55%; Tdeg = 316–320 ℃). Moreover, supplementation of the waste apple pulp extract led to the preparation of thicker membranes, with higher Young’s modulus, tension, and deformation at break but lower water uptake capacity and lower permeability to O2 and CO2. These results show that waste apple pulp and stale bread are suitable feedstocks for BC production and the cultivation conditions can be adjusted for tailoring the biopolymer’s mechanical and barrier properties to suit different applications.
Unidades organizacionais
Descrição
Palavras-chave
Contribuidores
Financiadores
Entidade financiadora
Fundação para a Ciência e a Tecnologia
Programa de financiamento
Número da atribuição
2021.05014.BD